Silverarc Capital Management’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,626
| Closed | -$1.32M | – | 86 |
|
|
2023
Q1 | $1.32M | Sell |
11,626
-7,095
| -38% | -$805K | 0.54% | 49 |
|
|
2022
Q4 | $2.1M | Buy |
18,721
+396
| +2% | +$44.4K | 0.6% | 45 |
|
|
2022
Q3 | $2.35M | Buy |
18,325
+937
| +5% | +$120K | 0.8% | 32 |
|
|
2022
Q2 | $1.19M | Buy |
17,388
+1,044
| +6% | +$71.6K | 0.37% | 41 |
|
|
2022
Q1 | $2.33K | Buy |
16,344
+314
| +2% | +$45 | 0.96% | 27 |
|
|
2021
Q4 | $2.67M | Buy |
16,030
+2,288
| +17% | +$381K | 1.08% | 29 |
|
|
2021
Q3 | $1.91M | Buy |
13,742
+10,546
| +330% | +$1.47M | 1.08% | 33 |
|
|
2021
Q2 | $1.52K | Sell |
3,196
-1,804
| -36% | -$860 | 0.68% | 51 |
|
|
2021
Q1 | $2.06M | Buy |
5,000
+3,750
| +300% | +$1.54M | 1.12% | 33 |
|
|
2020
Q4 | $613K | Buy |
+1,250
| New | +$613K | 0.36% | 65 |
|